Marianna Sargsyan
Cardiovascular Disease · Evanston, ILNPI 1215349162
Payments from drug & device makers
Across 128 payments — averaging $164.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$11K
- Abbott$3K
- Abiomed$2K
- Edwards Lifesciences$2K
- Teleflex LLC$1K
- Boston Scientific$442
- plus $1K from 12 others
What the payments were for
- Grants$7,40035%
- Travel & lodging$7,32535%
- Food & beverage$6,17729%
- Education$1441%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 46 | $11,155 |
| Abbott | 18 | $2,871 |
| Abiomed | 14 | $2,115 |
| Edwards Lifesciences | 14 | $1,783 |
| Teleflex LLC | 8 | $1,479 |
| Boston Scientific | 4 | $442 |
| Cardiovascular Systems Inc. | 5 | $342 |
| Stryker | 2 | $196 |
| Shockwave Medical, Inc | 1 | $146 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $112 |
| Acist Medical Systems, Inc. | 3 | $102 |
| AstraZeneca | 3 | $88 |
| Philips North America LLC | 1 | $87 |
| Novartis | 3 | $56 |
| Argon Medical Devices, Inc. | 1 | $24 |
| Lemaitre Vascular, Inc. | 1 | $22 |
| Kestra Medical Technology Services, Inc. | 1 | $16 |
| Chiesi USA, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- OPTIS$2,100
- RESOLUTE ONYX$1,545
- GUIDELINER$1,228
- Impella$1,198
- VenaSeal$877
- DRAGONFLY OPSTAR$346
- STINGRAY$256
- Diamondback Coronary$251
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$190
- FlowTriever$157
- Vascular Lithotripsy$146
- Resolute$144
- TURNPIKE$133
- Diamondback Peripheral$131
- Abre$124
- Xience Sierra Coronary Stent System$120
- Watchman$109
How this compares
$21,047 in reported general payments places this provider in the 85th percentile of 932 cardiovascular disease providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Metoprolol Succinate | 20 | $277 |
| Losartan Potassium | 14 | $37 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Evanston
- Robert GordonEvanston$413K
- Amit PursnaniEvanston$367K
- Steven SmartEvanston$165K
- Benjamin LumicaoChicago$3.7M
- Paul CremerChicago$2.9M
- Lokesh ChandraHazel Crest$2.7M
- Steven LupovitchArlington Heights$2.6M
- Nitasha SarswatChicago$2M
- Alan BrownNaperville$1.5M
- Alexander AdlerPeoria$1.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.